Hector Alila

Protalex, Inc. engages in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and Immune Thrombocytopenia. Its lead product is PRTX-100 which is a bacterial protein known to modify aspects of the human immune system. The company was founded by John E. Doherty on September 17, 1999 and is headquartered in Florham Park, NJ.

Esperance Pharmaceuticals, Inc. develops oncology products. It specializes in oncology products that selectively kill cancer cells without harming normal cells. The company was founded by Hector W. Alila in 2006 and is headquartered in Baton Rouge, LA.

Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer

gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.